TINA-QUANT HEMOGLOBIN A1C GEN.3 - HEMOLYSATE AND WHOLE BLOOD APPLICATION
Received Mar 26, 2025 · Event occurred Mar 3, 2025
Report 1823260-2025-00882 · MDR key 21696832
Device
Generic name
Assay, Glycosylated Hemoglobin
Manufacturer
Roche DiagnosticsCatalog number
05336163190
Lot number
ASKU
Product problems
- Incorrect, Inadequate or Imprecise Result or Readings
- High Test Results
- Incorrect, Inadequate or Imprecise Result or Readings
- High Test Results
Patient
NA · Unknown
- No Clinical Signs, Symptoms or Conditions
- No Clinical Signs, Symptoms or Conditions
Narrative
Additional Manufacturer Narrative
THE COBAS 8000 COBAS C 502 MODULE SERIAL NUMBER IS (B)(6). THE INVESTIGATION IS ONGOING.
Description of Event or Problem
THERE WAS AN ALLEGATION OF A QUESTIONABLE TINA-QUANT HEMOGLOBIN A1C GEN.3 - HEMOLYSATE AND WHOLE BLOOD APPLICATION RESULT FROM THE COBAS 8000 COBAS C 502 MODULE. THE INITIAL RESULT WAS 9.0%, AND THE REPEAT RESULT WAS 5.5%. THE QUESTIONABLE RESULT WAS REPEATED BECAUSE THE CUSTOMER NOTICED THAT IT DID NOT MATCH THE PATIENT'S PREVIOUS RESULT. THE REPEAT RESULT WAS DEEMED TO BE CORRECT.
Additional Manufacturer Narrative
IN THE ALARM TRACE, THERE WAS AN ALARM THAT THE WATER RESERVOIR LEVEL WAS TOO LOW AND AN ALARM FOR THE INCUBATION BATH WATER LEVEL SENSOR. QC AND CALIBRATION WERE PASSING. A FIELD SERVICE ENGINEER (FSE) DETERMINED THAT THE GEAR PUMP PRESSURE WAS SLIGHTLY LOW. THE FSE DECONTAMINATED THE ENTIRE ANALYZER, REPLACED ALL PIPETTOR SEALS, VACUUM VALVES, THE RINSE MECHANISM TUBING, DETERGENT VACUUM TUBING, ALL CELLS, VACUUM DIAPHRAGMS, FLAPPER VALVES, AND THE GEAR PUMP HEAD. HE VERIFIED THAT ALL MECHANISMS WERE ADJUSTED AND WORKING PROPERLY, VERIFIED ALL WATER AND VACUUM PRESSURES, AND RAN CALIBRATION AND QC THAT PASSED. THE INVESTIGATION WAS UNABLE TO DETERMINE A DIRECT ROOT CAUSE. THE CUSTOMER HAS NOT REPORTED ANY ADDITIONAL ISSUES AFTER THE SERVICE WAS PERFORMED.